• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
Gilead Sciences Completes Acquisition of MYR GmbH Business Wire (Press Release)13:43 4-Mar-21
In the last 7 days
Remdesivir was big success for Gilead. What’s next? Korea Biomedical Review02:56 3-Mar-21
Regulatory front for March 2, 2021 BioWorld17:55 2-Mar-21
In the last month
Gilead Sciences to Present at Upcoming Investor Conferences Business Wire (Press Release)13:05 18-Feb-21
BioSpace Movers & Shakers, Feb. 12 BioSpace14:00 12-Feb-21
Galapagos and Gilead Discontinue ISABELA Phase 3 Trials in IPF Business Wire (Press Release)14:02 10-Feb-21
3 Best Biotech Stocks to Buy Now The Motley Fool11:34 10-Feb-21
Governor Cooper Announces Gilead Sciences Will Create 275 Jobs in the Research Triangle Region Office of the North Carolina Governor (Press Release)16:21 9-Feb-21
Why Gilead Sciences Stock Jumped Today The Motley Fool20:33 5-Feb-21
Gilead says remdesivir drug unaffected by new strains of coronavirus Proactive Investors (USA & Canada)10:33 5-Feb-21
Gilead says remdesivir unaffected by new strains of COVID-19 Proactive Investors (USA & Canada)10:12 5-Feb-21
Gilead: 4Q Earnings Snapshot The Tribune, California21:26 4-Feb-21
view more headlines
4 Mar 13:43

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.